Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan

Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc. (NYSE:MRK) has a strong pipeline, there is an urgent need for Pfizer Inc. (NYSE:PFE) to make more acquisitions in order to keep its sales intact.

“[...] It is facing generic competition. Its blockbuster drugs, such as Lipitor and Enbrel, sales are going down. This will have an impact for a couple of quarters. The real concern for Pfizer Inc. (NYSE:PFE), I would say, is its other blockbuster drug, such as Celebrex in the arthritis painkiller market,” said Gopinathan.

According to Gopinathan, the tenure of patents for some of the key drugs of the company are about to expire, which should be an area of concern for the company. He said that Celebrex will lose patent in the U.S. later this year, followed by its key drug, Viagra in 2017 and Lyrica in 2018. Thus, Gopinathan explained that the sales of the company would shrink by 20% within next three to four years, as a result of patent expiration of three of its key drugs.

On the basis of these facts, Gopinathan recommends the idea of a takeover for the company.

” It’s very important that Pfizer Inc. (NYSE:PFE) has to go for some kind of acquisition to strengthen its pipeline and because of that, I think, Pfizer Inc. (NYSE:PFE) would come back with a sweetened offer for AstraZeneca plc (ADR) (NYSE:AZN), mostly in November this year,” he said.

The company abandoned its plants to acquire AstraZeneca plc (ADR) (NYSE:AZN) in May, when the latter turned down its $118 billion bid offer. In the meantime, the progress on cancer drugs and the company’s takeover strategy will be on focus during its conference call today.

Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!